FOURTEENTH AMENDMENT TO CREDIT AGREEMENTCredit Agreement • October 1st, 2020 • Venus Concept Inc. • Surgical & medical instruments & apparatus • New York
THIS FOURTEENTH AMENDMENT TO CREDIT AGREEMENT (this “Agreement”) dated as of September 30, 2020 (the “Fourteenth Amendment Effective Date”) is entered into among VENUS CONCEPT CANADA CORP., an Ontario corporation (“Venus Canada”), VENUS CONCEPT USA INC., a Delaware corporation (“Venus USA” and together with Venus Canada, each a “Borrower” and collectively, the “Borrowers”), VENUS CONCEPT LTD., an Israeli corporation (the “Parent”), VENUS CONCEPT INC., a Delaware corporation (the “Super Parent”), the Lenders party hereto and MADRYN HEALTH PARTNERS, LP, a Delaware limited partnership, as Administrative Agent. All capitalized terms used herein and not otherwise defined herein shall have the meanings given to such terms in the Credit Agreement (as defined below).
This AMENDING AGREEMENT is dated as of September 25, 2020. AMONG:Amending Agreement • October 1st, 2020 • Venus Concept Inc. • Surgical & medical instruments & apparatus
AMALGO CORPORATION (formerly Neograft Solutions Inc., the entity existing following the amalgamation of NeoGraft Solutions Inc., NeoGrafters Limited, and 1904247 Ontario Ltd.), (“Canadian Vendor Amalco”), a corporation existing under the laws of the Province of Ontario
